BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35120539)

  • 1. Assessing the feasibility, acceptability and accessibility of a peer-delivered intervention to reduce harm and improve the well-being of people who experience homelessness with problem substance use: the SHARPS study.
    Parkes T; Matheson C; Carver H; Foster R; Budd J; Liddell D; Wallace J; Pauly B; Fotopoulou M; Burley A; Anderson I; Price T; Schofield J; MacLennan G
    Harm Reduct J; 2022 Feb; 19(1):10. PubMed ID: 35120539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A peer-delivered intervention to reduce harm and improve the well-being of homeless people with problem substance use: the SHARPS feasibility mixed-methods study.
    Parkes T; Matheson C; Carver H; Foster R; Budd J; Liddell D; Wallace J; Pauly B; Fotopoulou M; Burley A; Anderson I; MacLennan G
    Health Technol Assess; 2022 Feb; 26(14):1-128. PubMed ID: 35212621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supporting Harm Reduction through Peer Support (SHARPS): testing the feasibility and acceptability of a peer-delivered, relational intervention for people with problem substance use who are homeless, to improve health outcomes, quality of life and social functioning and reduce harms: study protocol.
    Parkes T; Matheson C; Carver H; Budd J; Liddell D; Wallace J; Pauly B; Fotopoulou M; Burley A; Anderson I; MacLennan G; Foster R
    Pilot Feasibility Stud; 2019; 5():64. PubMed ID: 31164989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "You know, we can change the services to suit the circumstances of what is happening in the world": a rapid case study of the COVID-19 response across city centre homelessness and health services in Edinburgh, Scotland.
    Parkes T; Carver H; Masterton W; Falzon D; Dumbrell J; Grant S; Wilson I
    Harm Reduct J; 2021 Jun; 18(1):64. PubMed ID: 34118942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: a randomised clinical trial.
    Collins SE; Duncan MH; Saxon AJ; Taylor EM; Mayberry N; Merrill JO; Hoffmann GE; Clifasefi SL; Ries RK
    Lancet Psychiatry; 2021 Apr; 8(4):287-300. PubMed ID: 33713622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An intervention to improve the quality of life in children of parents with serious mental illness: the Young SMILES feasibility RCT.
    Abel KM; Bee P; Gega L; Gellatly J; Kolade A; Hunter D; Callender C; Carter LA; Meacock R; Bower P; Stanley N; Calam R; Wolpert M; Stewart P; Emsley R; Holt K; Linklater H; Douglas S; Stokes-Crossley B; Green J
    Health Technol Assess; 2020 Nov; 24(59):1-136. PubMed ID: 33196410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provision of peer support at the intersection of homelessness and problem substance use services: a systematic 'state of the art' review.
    Miler JA; Carver H; Foster R; Parkes T
    BMC Public Health; 2020 May; 20(1):641. PubMed ID: 32381086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptance and commitment therapy for older people with treatment-resistant generalised anxiety disorder: the FACTOID feasibility study.
    Gould RL; Wetherell JL; Serfaty MA; Kimona K; Lawrence V; Jones R; Livingston G; Wilkinson P; Walters K; Novere ML; Howard RJ
    Health Technol Assess; 2021 Sep; 25(54):1-150. PubMed ID: 34542399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive review of prioritised interventions to improve the health and wellbeing of persons with lived experience of homelessness.
    Moledina A; Magwood O; Agbata E; Hung JH; Saad A; Thavorn K; Pottie K
    Campbell Syst Rev; 2021 Jun; 17(2):e1154. PubMed ID: 37131928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What constitutes effective problematic substance use treatment from the perspective of people who are homeless? A systematic review and meta-ethnography.
    Carver H; Ring N; Miler J; Parkes T
    Harm Reduct J; 2020 Jan; 17(1):10. PubMed ID: 32005119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions to reduce tobacco use in people experiencing homelessness.
    Vijayaraghavan M; Elser H; Frazer K; Lindson N; Apollonio D
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013413. PubMed ID: 33284989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Youth social behaviour and network therapy (Y-SBNT): adaptation of a family and social network intervention for young people who misuse alcohol and drugs - a randomised controlled feasibility trial.
    Watson J; Toner P; Day E; Back D; Brady LM; Fairhurst C; Renwick C; Templeton L; Akhtar S; Lloyd C; Li J; Cocks K; Ambegaokar S; Parrott S; McArdle P; Gilvarry E; Copello A
    Health Technol Assess; 2017 Mar; 21(15):1-260. PubMed ID: 28399988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualised placement and support programme for people unemployed because of chronic pain: a feasibility study and the InSTEP pilot RCT.
    Linaker C; Fraser S; Price C; Maguire N; Little P; Madan I; Pinedo-Villanueva R; Coggon D; Cooper C; Ntani G; Walker-Bone K
    Health Technol Assess; 2021 Jan; 25(5):1-72. PubMed ID: 33501902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the need for alcohol harm reduction and managed alcohol programs for people experiencing homelessness and alcohol use disorders in Scotland.
    Carver H; Parkes T; Browne T; Matheson C; Pauly B
    Drug Alcohol Rev; 2021 Feb; 40(2):220-230. PubMed ID: 33006255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline characteristics of people experiencing homelessness with a recent drug overdose in the PHOENIx pilot randomised controlled trial.
    Lowrie R; McPherson A; Mair FS; Stock K; Jones C; Maguire D; Paudyal V; Duncan C; Blair B; Lombard C; Ross S; Hughes F; Moir J; Scott A; Reilly F; Sills L; Hislop J; Farmer N; Lucey S; Wishart S; Provan G; Robertson R; Williamson A
    Harm Reduct J; 2023 Apr; 20(1):46. PubMed ID: 37016418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "PPI? That sounds like Payment Protection Insurance": Reflections and learning from a substance use and homelessness study Experts by Experience group.
    Foster R; Carver H; Wallace J; Dunedin A; Burridge S; Foley P; Pauly B; Parkes T
    Res Involv Engagem; 2021 Nov; 7(1):82. PubMed ID: 34801090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration, effectiveness and costs of different models of primary health care provision for people who are homeless: an evaluation study.
    Crane M; Joly L; Daly BJ; Gage H; Manthorpe J; Cetrano G; Ford C; Williams P
    Health Soc Care Deliv Res; 2023 Oct; 11(16):1-217. PubMed ID: 37839804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AMBER care bundle for hospital inpatients with uncertain recovery nearing the end of life: the ImproveCare feasibility cluster RCT.
    Koffman J; Yorganci E; Murtagh F; Yi D; Gao W; Barclay S; Pickles A; Higginson I; Johnson H; Wilson R; Bailey S; Ewart C; Evans C
    Health Technol Assess; 2019 Oct; 23(55):1-150. PubMed ID: 31594555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of harm reduction treatment for alcohol (HaRT-A) for people experiencing homelessness and alcohol use disorder.
    Collins SE; Clifasefi SL; Nelson LA; Stanton J; Goldstein SC; Taylor EM; Hoffmann G; King VL; Hatsukami AS; Cunningham ZL; Taylor E; Mayberry N; Malone DK; Jackson TR
    Int J Drug Policy; 2019 May; 67():24-33. PubMed ID: 30851620
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.